Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John S Yu

Showing results (1-10 of 96) with videos related to

Pageof 10
Sort By:
The Medical Journal of Australia|November 26, 2003
An Australian with a Chinese faceJohn S Yu
Human Vaccines & Immunotherapeutics|July 3, 2013
Profile: ImmunoCellular Therapeutics LtdJohn S Yu
Methods in Molecular Biology (Clifton, N.J.)|July 8, 2009
Pituitary adenoma stem cellsPatrizia Tunici, John S Yu
The Lancet. Oncology|December 3, 2005
Quality of life for patients with glioblastomaJohn S Yu, Jennice Vilhauer
Expert Review of Neurotherapeutics|October 18, 2007
Cancer vaccines: a novel strategy to sensitize malignant glioma to chemotherapyGentao Liu, John S Yu
Journal of Neuro-Oncology|June 2, 2019
Triptolide reverses helper T cell inhibition and down-regulates IFN-γ induced PD-L1 expression in glioma cell linesLei Zhang, John S Yu
Aging Cell|April 3, 2025
Harnessing Immune Rejuvenation: Advances in Overcoming T Cell Senescence and Exhaustion in Cancer ImmunotherapyTesfahun Dessale Admasu, John S Yu
Cancer Letters|July 27, 2017
Metabolic regulation of glioma stem-like cells in the tumor micro-environmentTom M Thomas, John S Yu
Reviews on Recent Clinical Trials|May 14, 2008
Dendritic cell immunotherapy for malignant gliomasAnne Luptrawan, Gentao Liu, John S Yu
Advances in Experimental Medicine and Biology|May 29, 2012
Glioma stem cell research for the development of immunotherapyQijin Xu, Xiangpeng Yuan, John S Yu
Pageof 10

Showing results (1-10 of 96) with videos related to

Sort By:
Pageof 10
The Medical Journal of Australia|November 26, 2003
An Australian with a Chinese faceJohn S Yu
Human Vaccines & Immunotherapeutics|July 3, 2013
Profile: ImmunoCellular Therapeutics LtdJohn S Yu
Methods in Molecular Biology (Clifton, N.J.)|July 8, 2009
Pituitary adenoma stem cellsPatrizia Tunici, John S Yu
The Lancet. Oncology|December 3, 2005
Quality of life for patients with glioblastomaJohn S Yu, Jennice Vilhauer
Expert Review of Neurotherapeutics|October 18, 2007
Cancer vaccines: a novel strategy to sensitize malignant glioma to chemotherapyGentao Liu, John S Yu
Journal of Neuro-Oncology|June 2, 2019
Triptolide reverses helper T cell inhibition and down-regulates IFN-γ induced PD-L1 expression in glioma cell linesLei Zhang, John S Yu
Aging Cell|April 3, 2025
Harnessing Immune Rejuvenation: Advances in Overcoming T Cell Senescence and Exhaustion in Cancer ImmunotherapyTesfahun Dessale Admasu, John S Yu
Cancer Letters|July 27, 2017
Metabolic regulation of glioma stem-like cells in the tumor micro-environmentTom M Thomas, John S Yu
Reviews on Recent Clinical Trials|May 14, 2008
Dendritic cell immunotherapy for malignant gliomasAnne Luptrawan, Gentao Liu, John S Yu
Advances in Experimental Medicine and Biology|May 29, 2012
Glioma stem cell research for the development of immunotherapyQijin Xu, Xiangpeng Yuan, John S Yu
Pageof 10